Healthcare Services

Global Predictive Genetic Testing And Consumer Genomics Market Set for Strong Expansion Reaching $18.61 Billion by 2030 at 15.4% CAGR

April 6, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Predictive Genetic Testing And Consumer Genomics Market During The Forecast Period 2026–2030?

The predictive genetic testing and consumer genomics market has experienced substantial expansion in its size over recent years. It is anticipated to increase from $9.07 billion in 2025 to $10.49 billion in 2026, showing a compound annual growth rate (CAGR) of 15.7%. The expansion observed in the historic period can be linked to factors such as the growth of consumer health awareness, the expansion of genetic testing accessibility, the rising availability of affordable sequencing technologies, an increasing interest in ancestry testing, and the development of digital health ecosystems.

The predictive genetic testing and consumer genomics market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $18.61 billion, demonstrating a compound annual growth rate (CAGR) of 15.4%. This projected growth stems from several factors, including a heightened demand for personalized preventive healthcare, the increasing uptake of pharmacogenomic testing, the broadening reach of consumer genomics platforms, greater integration with digital health applications, and enhanced regulatory scrutiny concerning genetic data utilization. Key trends expected during this period involve the rising popularity of direct-to-consumer genetic testing, wider utilization of digital health platforms, an increasing desire for preventive health information, the proliferation of at-home sample collection kits, and an intensified emphasis on data privacy and security.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

What Drivers Are Expected To Influence The Predictive Genetic Testing And Consumer Genomics Market During The Forecast Period?

Increasing recognition of personalized medicine is anticipated to drive expansion in the predictive genetic testing and consumer genomics market in the future. This medical approach involves tailoring treatment and prevention plans for individuals, considering their unique genetic makeup, lifestyle choices, and environmental influences. Awareness of personalized medicine is expanding due to its capacity to enhance treatment efficacy through aligning therapies with a patient’s distinct biological traits. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic predispositions and characteristics, thereby facilitating customized prevention, prompt diagnosis, and treatment plans congruent with an individual’s genetic profile. An example supporting this trend is seen in February 2024, when the Personalized Medicine Coalition, a US-based professional membership organization, reported that the Food and Drug Administration (FDA) had sanctioned 16 new personalized medicines in 2023, marking a rise from the 6 approved in 2022. Consequently, the heightened awareness of personalized medicine serves as a key driver for the growth of the predictive genetic testing and consumer genomics market.

What Market Segments Are Evaluated Within The Predictive Genetic Testing And Consumer Genomics Market?

The predictive genetic testing and consumer genomics market covered in this report is segmented –

1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

Subsegments:

1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

What Key Developments And Trends Are Impacting The Predictive Genetic Testing And Consumer Genomics Market?

Major companies operating in the predictive genetic testing and consumer genomics market are prioritizing technological advancements, such as high-throughput and cost-efficient sequencing, to facilitate large-scale, accurate, and affordable genomic analysis. High-throughput and cost-efficient sequencing refers to the ability to process a massive quantity of genomes quickly while simultaneously reducing per-genome costs, making population-level testing achievable. For instance, in February 2024, Ultima Genomics Inc., a U.S.-based sequencing company, launched its UG 100 sequencing system, featuring the ppmSeq extreme-accuracy mode, which offers up to 6–8 billion reads per wafer with dual-wafer runs reaching approximately 4.8 Tb and expected run times under 14 hours. Constructed with a wafer-based substrate and flexible reagent cartridges, the system supports an industry-leading ~$100-genome roadmap via reagent costs of roughly $2,000 per wafer. The ppmSeq mode enables Q60 SNV raw-read accuracy without the need for additional workflow steps. With its blend of low reagent cost, high automation, and AI-driven variant calling, the UG 100 is positioned for extensive applications across consumer genomics, population screening, clinical WGS, pharmacogenomics, and large-scale research. Overall, the platform delivers faster, more scalable, and more affordable genomic data generation compared to legacy NGS technologies.

Who Are The Top Market Participants Influencing The Predictive Genetic Testing And Consumer Genomics Market?

Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation

Read the full predictive genetic testing and consumer genomics market report here:

https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

Which Region Is Forecast To Lead The Predictive Genetic Testing And Consumer Genomics Market In Terms Of Market Size?

North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Predictive Genetic Testing And Consumer Genomics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company

Property Management Software Market

https://www.thebusinessresearchcompany.com/report/property-management-software-market

Property Management Service Global Market Report

https://www.thebusinessresearchcompany.com/report/property-management-service-global-market-report

Commercial Property Insurance Global Market Report

https://www.thebusinessresearchcompany.com/report/commercial-property-insurance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795